SAN DIEGO, Oct. 15 /PRNewswire/ -- CareFusion (NYSE: CFN), a leading, global medical device company, issued the following update regarding its previously disclosed recall of approximately 17,000 ...

CareFusion is warning customers over problems with the PC unit of its Alaris infusion pump.--Courtesy of CareFusion CareFusion's ($CFN) Alaris infusion pumps are back ...

The US Food and Drug Administration (FDA) has notified healthcare providers of a class 1 recall of CareFusion's Alaris PC unit (model 8015) with software version 9.12. The Alaris PC unit is the ...

CareFusion is recalling 7,418 units of its Alaris Syringe infusion pump, a corrective action that the FDA just deemed Class 1. This marks CareFusion's ninth Class 1 recall of an Alaris device since ...

CareFusion Corporation has initiated a class 1 recall of the Alaris PC unit model 8015 with software version 9.12 because of a voltage problem, according to the US Food and Drug Administration (FDA).

DUBLIN, Ohio — Cardinal Health spinoff CareFusion will resume shipments of its most important drug-delivery pumps that had been stopped over a software glitch, the company said Friday. Cardinal ...

CHICAGO, July 10 (Reuters) - Carefusion, the medical products business being spun off by Cardinal Health Inc , said it will resume shipments of its Alaris medication infusion pumps. Shipments had been ...

CHICAGO, Jan 11 (Reuters) - CareFusion Corp said on Monday U.S. regulators have lifted an injunction on sales of its Alaris SE drug infusion pump, allowing the company to resume manufacturing and ...

WellSpan Health and CareFusion, a BD company (NYSE: BDX), today announced the successful implementation of the Alaris ® System across all four WellSpan hospitals, with WellSpan York Hospital becoming ...

CareFusion has announced it has reached an agreement with Epic to make bi-directional connectivity available between CareFusion’s Alaris system and Epic’s electronic medical record platform, according ...

FRANKLIN LAKES, N.J., Sept. 21, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced ...